Immunological considerations in the development of Pseudomonas aeruginosa vaccines
Pseudomonas aeruginosa is an opportunistic human pathogen capable of causing a wide range of potentially life-threatening infections. With multidrug-resistant P. aeruginosa infections on the rise, the need for a rationally-designed vaccine against this pathogen is critical. A number of vaccine platf...
Main Authors: | Sarah M. Baker, James B. McLachlan, Lisa A. Morici |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-02-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2019.1650999 |
Similar Items
-
Development of a Chimeric Vaccine Against Pseudomonas aeruginosa Based on the Th17-Stimulating Epitopes of PcrV and AmpC
by: Ying Wang, et al.
Published: (2021-01-01) -
Autoinducer-2 promotes Pseudomonas aeruginosa PAO1 acute lung infection via the IL-17A pathway
by: Hongdong Li, et al.
Published: (2022-08-01) -
Extract From Tetrastigma hemsleyanum Leaf Alleviates Pseudomonas aeruginosa Lung Infection: Network Pharmacology Analysis and Experimental Evidence
by: Tian-ling Lou, et al.
Published: (2021-07-01) -
A <i>Pseudomonas aeruginosa</i>-Derived Particulate Vaccine Protects against <i>P. aeruginosa</i> Infection
by: Zennia Jean C. Gonzaga, et al.
Published: (2021-07-01) -
Evaluation of Selected Parameters of the Specific Immune Response against <i>Pseudomonas aeruginosa</i> Strains
by: Michał Dzik, et al.
Published: (2021-12-01)